课题基金 / 基金详情

SAR OF INTERLEUKIN 2 AND IL-2 RELATED PEPTIDES

SAR OF INTERLEUKIN 2 AND IL-2 RELATED PEPTIDES
白细胞介素 2 和 IL-2 相关肽的 SAR
批准号:
3135434
负责人:
THOMAS L CIARDELLI
金额:
$12.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1989-06-30

项目摘要

项目成果

THOMAS L CIARDELLI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goal of this research plan is two-fold. First, to identify which of the 133 amino acid residues comprising the interleukin 2 primary sequence participate in receptor binding and the expression of biologic activity; and second, to utilize this information to design IL-2 related peptides with potential therapeutic utility having agonist and antagonist activity. We will utilize recombinant DNA derived proteins, synthetic peptides and monoclonal antibodies combined with analytical, physical and biologic assay methods to achieve the first part of our goal. Then, knowing which regions of IL-2 are important, we will use computer assisted molecular modeling to help design analogs which retain the proper stereochemical relationships required for agonist activity or receptor binding. We will also design potential IL-2 antagonists using similar techniques and the knowledge of the sequence of an Il-2 binding cell surface protein. We will prepare and purify the compounds and determine their activity in the Il-2 bioassay and competitive radioreceptor assay.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--MACROMOLECULAR LABORATORY RESOURCE
  • 批准号:
    6447957
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2001
  • 负责人:
    THOMAS L CIARDELLI
  • 依托单位:
CORE--MACROMOLECULAR LABORATORY RESOURCE
  • 批准号:
    6573848
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2001
  • 负责人:
    THOMAS L CIARDELLI
  • 依托单位:
CORE--MACROMOLECULAR LABORATORY RESOURCE
  • 批准号:
    6357020
  • 项目类别:
  • 资助金额:
    $24.84万
  • 财政年份:
    2000
  • 负责人:
    THOMAS L CIARDELLI
  • 依托单位:
CORE--MACROMOLECULAR LABORATORY RESOURCE
  • 批准号:
    6217349
  • 项目类别:
  • 资助金额:
    $13.79万
  • 财政年份:
    1999
  • 负责人:
    THOMAS L CIARDELLI
  • 依托单位:
海外基金